Novartis Financial Results – Q3 2023
Novartis Financial Results – Q3 2023
weberfr8
Fri, 10/20/2023 – 14:36
Read more about Novartis Financial Results – Q3 2023
PrintPDF
Entries by weberfr8
Novartis condemns the terrorist actions against people in Israel and loss of innocent lives
Novartis condemns the terrorist actions against people in Israel and loss of innocent lives
weberfr8
Fri, 10/13/2023 – 13:02
Read more about Novartis condemns the terrorist actions against people in Israel and loss of innocent lives
PrintPDF
Novartis statement on collaboration and license agreement for tislelizumab with BeiGene, Ltd.
Novartis statement on collaboration and license agreement for tislelizumab with BeiGene, Ltd.
weberfr8
Tue, 09/19/2023 – 14:30
Read more about Novartis statement on collaboration and license agreement for tislelizumab with BeiGene, Ltd.
PrintPDF
Novartis statement on collaboration and license agreement for tislelizumab with BeiGene, Ltd.
Novartis statement on collaboration and license agreement for tislelizumab with BeiGene, Ltd.
weberfr8
Tue, 09/19/2023 – 14:30
Read more about Novartis statement on collaboration and license agreement for tislelizumab with BeiGene, Ltd.
PrintPDF
